An update on respiratory syncytial virus antiviral agents

By Prince G.A.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 2, 2001-02 ,pp. : 297-308

Informa Healthcare

Access to resources Recommend Favorite

Recent progress in antiviral chemotherapy for respiratory syncytial virus infections

By Shigeta S.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 2, 2000-02 ,pp. : 221-235

Informa Healthcare

Access to resources Recommend Favorite

The development of antiviral therapy and vaccines against respiratory syncytial virus and human parainfluenza virus type 3

By A J.E.  

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 4, 2001-08 ,pp. : 175-190

Adis International

Access to resources Recommend Favorite

Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy

By Bolger Gordon   Lapeyre Nicole   Dansereau Nathalie   Lagacé Lisette   Berry Gerald   Klosowski Katy   Mewhort Tracy   Liuzzi Michel  

Canadian Journal of Physiology and Pharmacology, Vol. 83, Iss. 2, 2005-02 ,pp. : 198-213

NRC Research Press

Access to resources Recommend Favorite

Erratum: Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy

By Bolger Gordon   Lapeyre Nicole   Dansereau Nathalie   Lagacé Lisette   Berry Gerald   Klosowski Katy   Mewhort Tracy   Liuzzi Michel  

Canadian Journal of Physiology and Pharmacology, Vol. 83, Iss. 3, 2005-03 ,pp. : 319-319

NRC Research Press

Access to resources Recommend Favorite